Quantcast
Last updated on April 16, 2014 at 5:31 EDT

Latest Cepheid variable Stories

2012-10-03 10:20:08

WASHINGTON, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Astronomers using NASA's Spitzer Space Telescope have announced the most precise measurement yet of the Hubble constant, or the rate at which our universe is stretching apart. (Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO) The Hubble constant is named after the astronomer Edwin P. Hubble, who astonished the world in the 1920s by confirming our universe has been expanding since it exploded into being 13.7 billion years ago....

2012-08-09 10:25:58

SUNNYVALE, Calif., Aug. 9, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. Wedbush PacGrow Life Sciences Conference, New York, NYWednesday, August 15, 2012 at 10.20 a.m. Eastern Time Baird Health Care Conference, New York, NYThursday, September 6, 2012 at 12.10 p.m. Eastern Time Morgan Stanley Global Healthcare Conference, New York, NYWednesday, September 12,...

2012-08-06 10:24:42

SUNNYVALE, Calif., Aug. 6, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced the first in a series of agreements with the Bill & Melinda Gates Foundation, the United States President's Emergency Plan for AIDS Relief (PEPFAR), the United States Agency for International Development (USAID) and UNITAID to buy-down the price of the Xpert(®) MTB/RIF test in an effort to drive adoption of the technology as a critical tool in interrupting the transmission cycle of tuberculosis....

2012-06-14 06:24:32

SUNNYVALE, Calif., June 14, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today welcomed UNITAID's announcement that it has approved funding of $30 million to scale up access to the "ground-breaking" Xpert MTB/RIF in high burden developing countries (HBDC). According to UNITAID, the funds will be used to roll out Xpert-based programs in around 20 countries, in addition to supporting a buy-down of the price of each Xpert MTB/RIF cartridge from $17 currently to around $10. "We are...

2012-05-31 10:25:07

SUNNYVALE, Calif., May 31, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast. Jefferies Global Healthcare Conference, New York, NYTuesday, June 5, 2012 at 10.30 a.m. Eastern Time Goldman Sachs Healthcare Conference, Rancho Palos Verdes, CAWednesday, June 6, 2012 at 10.40 a.m. Pacific Time William Blair Growth Conference, Chicago, ILTuesday, June 12, 2012 at...

2012-05-24 02:27:44

SUNNYVALE, Calif., May 24, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that the U.S. Food & Drug Administration (FDA) has cleared its GeneXpert®( )Infinity-80 System, a high-throughput automated molecular system designed to deliver around-the-clock results for a wide variety of clinical testing applications. The GeneXpert Infinity-80 has been initially cleared in conjunction with Cepheid's Xpert® Flu test. "With the capability of generating more than two thousand...

2012-05-23 02:26:09

SUNNYVALE, Calif., May 23, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that both Xpert® CT/NG and Xpert® CT have received CE marking, with shipments expected to begin immediately. Running on Cepheid's GeneXpert® System, the products are qualitative in vitro molecular diagnostic tests for the rapid detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). With results in less than 90 minutes, new opportunities for same-day patient...

2012-05-01 10:21:24

INDIANAPOLIS, May 1, 2012 /PRNewswire/ -- The Diagnostic Marketing Association (DxMA), serving marketing, regulatory and medical affairs professionals in the diagnostic and device market segments, today presented its 2011 Marketer of the Year Award to Cepheid (Nasdaq: CPHD), a leading molecular diagnostics company. Presented at the annual DxMA Global Marketing Summit, the award recognizes innovation by marketers seeking to highlight their company and products at the leading edge of the...

2012-04-26 10:25:29

SUNNYVALE, Calif., April 26, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast. Deutsche Bank Health Care Conference, Boston, MA Wednesday, May 9, 2012 at 10.00 a.m. Eastern Time Baird Growth Conference, Chicago, IL Thursday, May 10, 2012 at 9.30 a.m....

2012-03-20 02:23:51

SUNNYVALE, Calif., March 20, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that, together with the University of Medicine and Dentistry of New Jersey (UMDNJ), it has received a grant from the National Institutes of Health to develop sample processing and amplification methods for highly-sensitive detection of bloodstream bacteria using nested polymerase chain reaction (PCR) on the GeneXpert® System. The $1.3 million grant is for the first year of an expected five-year, $5.5...


Latest Cepheid variable Reference Libraries

3_3fe163858980bcaf7ae60a0ecf315c192
2004-10-19 04:45:40

Andromeda Galaxy -- The Andromeda Galaxy, also known as M31, or the object 31 on the catalog of Messier, is the other giant spiral galaxy in the Local Group, together with our galaxy, the Milky Way. It is at a distance of approximately 2.36 million light years or 725 kpc, in the direction of the constellation Andromeda, and it will probably merge in the future with our galaxy, to form a giant elliptical. With a mass of about 1.5 times more than the Milky Way, it is the dominant galaxy...

More Articles (1 articles) »